Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 2-formylphenoxyacetic Acid Isonicotinylhydrazone
2. Aconiazide
1. Aconiazide
2. Ncgc00160674-01
3. {2-[(e)-(isonicotinoylhydrazono)methyl]phenoxy}acetic Acid
4. Aconiazide [inn]
5. 8okq9ns8mo
6. 13410-86-1
7. Aconiazide [mart.]
8. Dsstox_cid_26292
9. Dsstox_rid_81518
10. Dsstox_gsid_46292
11. Schembl635283
12. Chembl1590674
13. Dtxsid8046292
14. Tox21_111977
15. Stk181710
16. Akos001031966
17. Cas-13410-86-1
18. Sr-01000872617
19. Sr-01000872617-2
20. Isonicotinic Acid (2-(carboxymethoxy)benzylidene)hydrazide
21. 2-(2-{[2-(4-pyridylcarbonyl)hydrazinylidene]methyl}phenoxy)acetic Acid
22. (2-{(e)-[2-(pyridin-4-ylcarbonyl)hydrazinylidene]methyl}phenoxy)acetic Acid
| Molecular Weight | 299.28 g/mol |
|---|---|
| Molecular Formula | C15H13N3O4 |
| XLogP3 | 1.3 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 6 |
| Exact Mass | 299.09060590 g/mol |
| Monoisotopic Mass | 299.09060590 g/mol |
| Topological Polar Surface Area | 101 Ų |
| Heavy Atom Count | 22 |
| Formal Charge | 0 |
| Complexity | 408 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Antitubercular Agents
Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. (See all compounds classified as Antitubercular Agents.)
ABOUT THIS PAGE
A Aconiazide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Aconiazide, including repackagers and relabelers. The FDA regulates Aconiazide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Aconiazide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Aconiazide supplier is an individual or a company that provides Aconiazide active pharmaceutical ingredient (API) or Aconiazide finished formulations upon request. The Aconiazide suppliers may include Aconiazide API manufacturers, exporters, distributors and traders.
click here to find a list of Aconiazide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Aconiazide DMF (Drug Master File) is a document detailing the whole manufacturing process of Aconiazide active pharmaceutical ingredient (API) in detail. Different forms of Aconiazide DMFs exist exist since differing nations have different regulations, such as Aconiazide USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Aconiazide DMF submitted to regulatory agencies in the US is known as a USDMF. Aconiazide USDMF includes data on Aconiazide's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Aconiazide USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Aconiazide suppliers with USDMF on PharmaCompass.
Aconiazide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Aconiazide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Aconiazide GMP manufacturer or Aconiazide GMP API supplier for your needs.
A Aconiazide CoA (Certificate of Analysis) is a formal document that attests to Aconiazide's compliance with Aconiazide specifications and serves as a tool for batch-level quality control.
Aconiazide CoA mostly includes findings from lab analyses of a specific batch. For each Aconiazide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Aconiazide may be tested according to a variety of international standards, such as European Pharmacopoeia (Aconiazide EP), Aconiazide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Aconiazide USP).
LOOKING FOR A SUPPLIER?
